Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 182
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Am J Med Genet A ; 155A(8): 1798-802, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21739599

ABSTRACT

Chronic intestinal pseudo-obstruction (CIPO) can occur as a consequence of neuropathies including diffuse Intestinal Neuronal Dysplasia (IND), a relatively rare enteric nervous system (ENS) abnormality. Although various authors reported of diffuse IND associated either with intestinal malrotation or megacystis, the co-existence of these three entities in the same patient has never been described before. The aim of this paper is to report for the first time in literature a series of patient with such association, focusing on one who carries a de novo duplication of chromosome 12, suggesting a new syndromic association (megacolon, megacystis, malrotation).


Subject(s)
Abnormalities, Multiple/genetics , Enteric Nervous System/abnormalities , Fetal Diseases/diagnosis , Gastrointestinal Tract/abnormalities , Megacolon/diagnosis , Torsion Abnormality/diagnosis , Child, Preschool , Chromosome Duplication , Chromosomes, Human, Pair 12/genetics , Comparative Genomic Hybridization , Duodenum/abnormalities , Fatal Outcome , Female , Fetal Diseases/genetics , Fetal Diseases/therapy , Gastrointestinal Tract/surgery , Humans , Ileostomy , Megacolon/genetics , Megacolon/surgery , Syndrome , Torsion Abnormality/genetics , Torsion Abnormality/surgery , Urinary Bladder/abnormalities
2.
J Endocrinol Invest ; 34(4): 287-91, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20414046

ABSTRACT

BACKGROUND: Hypothalamic amenorrhea (HA) is characterized by neuroendocrine impairment that, in turn, negatively modulates endocrine function, mainly within the reproductive axis. HA presents with hypo-LH, hypoestrogenism and, until now, a definite therapeutic strategy has not yet been found. The aim of the following study was to test the efficacy of acetyl-L-carnitine (ALC) administration in HA-affected subjects. POPULATION: Twenty-four patients affected by stress-induced HA were divided into two groups according to LH plasma levels: group A, hypo-LH (LH≤3 mIU/ml; no.=16), and group B, normo-LH (LH>3 mIU/ml; no.=8), were treated with ALC (1 g/day, per os) for 16 weeks. DESIGN: Patients underwent baseline hormonal assessment, pulsatility test (for LH and FSH), naloxone test (for LH, FSH and cortisol) both before and after 16 weeks of treatment. RESULTS: Under ALC administration hypo-LH patients showed a significant increase in LH plasma levels (from 1.4±0.3 to 3.1±0.5 mIU/ml, p<0.01) and in LH pulse amplitude (p<0.001). No changes were observed in the normo-LH group. LH response to naloxone was restored under ALC therapy. Maximal LH response and area under the curve under naloxone were significantly increased (p<0.05 and p<0.01, respectively). No changes were observed in the normo-LH patients. CONCLUSIONS: Our data support the hypothesis of a specific role of ALC on counteracting the stress-induced abnormalities in hypo-LH patients affected by hypothalamic amenorrhea.


Subject(s)
Acetylcarnitine/therapeutic use , Amenorrhea/drug therapy , Amenorrhea/physiopathology , Hypogonadism/drug therapy , Hypothalamic Diseases/drug therapy , Reproduction/drug effects , Adult , Amenorrhea/blood , Female , Humans , Hypogonadism/blood , Hypogonadism/physiopathology , Hypothalamic Diseases/blood , Hypothalamic Diseases/physiopathology , Insulin/blood , Luteinizing Hormone/blood , Reproduction/physiology , Stress, Physiological , Young Adult
3.
Pediatr Surg Int ; 26(8): 819-24, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20563872

ABSTRACT

PURPOSE: Tunneled indwelling central venous catheters (CVC) are essential in the management of children with cancer, hematological, nephrological disorders and for parenteral nutrition. The aim of this study is to present the experience of a single center of the transition from traditional open surgical cut down procedure (OSC) to ultrasound (US)-guided percutaneous CVC insertion, focusing on learning curve and related complications. METHODS: All CVCs inserted between April 2008 and November 2009 in children at the Gaslini Children Hospital were revised, and data on methods of cannulation, intraoperative and device-related complications and re-intervention were recorded. RESULTS: 194 CVCs were positioned in 188 patients. 128 out of 194 CVCs were positioned through an OSC technique, whereas the remaining 66 CVCs were inserted percutaneously with US guidance. Of the 27 recorded complications, 15 were mechanical events, 7 cases developed infection, whereas the remaining 5 (2.6%) were classified as intraoperative complications. A second surgical procedure was described in 23 (11.8%) cases. CONCLUSION: Shifting from OSC to US-guided percutaneous CVC insertion inevitably involves a challenging learning curve which is generally associated with high complication rates. Complications progressively decrease once a good experience in US guidance and percutaneous technique has been obtained.


Subject(s)
Catheterization, Central Venous/methods , Catheters, Indwelling , Clinical Competence , Ultrasonography, Interventional , Vascular Surgical Procedures/education , Vascular Surgical Procedures/methods , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Italy/epidemiology , Male , Postoperative Complications/epidemiology , Treatment Outcome
4.
Pediatr Surg Int ; 26(5): 465-71, 2010 May.
Article in English | MEDLINE | ID: mdl-20306059

ABSTRACT

INTRODUCTION: The most invalidating and life-threatening complication in Hirschsprung's disease patients (HSCR) is Hirschsprung's disease-associated enterocolitis (HAEC). The mechanisms underlying enterocolitis have not been identified. The limited knowledge of the role of intestinal microflora is in part due to the complexity of the intestinal microbiome and to the limitation of cultivation-based technologies, given that less than 25% of the intestinal bacterial species can be cultured. MATERIALS AND METHODS: We used amplified ribosomal DNA restriction analysis (ARDRA) with four different restriction enzymes to study variations of microflora composition of the stools of a selected HSCR patient in different clinical conditions (acute phase vs. remission). RESULTS: We assessed a total of 15 stool specimens belonging to the same 3-year-old male patient suffering from HSCR, which were harvested during 4 HAEC episodes and remission phases. Restriction analysis showed that HAEC episodes seem to cluster together at ARDRA analysis, thus suggesting a sort of predisposing bacterial community for HAEC development and the need for a microflora equilibrium to maintain wellness. CONCLUSIONS: This approach proved to be effective, useful and powerful in assessing microflora dynamics and indicated that the differences in microflora associated with acute HAEC or remission are likely to result from a combination of disease activity and different antibiotic therapies. ARDRA proved to be useful in discriminating disease versus remission. Our findings indicated that HAEC results from a change in the equilibrium between bacterial species or from altered discrimination of harmless from harmful microorganisms, challenging the definition of pathogenic and non-pathogenic species. Based on these results, we propose ARDRA as a rapid inexpensive tool to assess microflora dynamics during HAEC episodes.


Subject(s)
Bacteria/classification , Enterocolitis/microbiology , Hirschsprung Disease/complications , Alleles , Anti-Infective Agents/therapeutic use , Bacteria/genetics , Child, Preschool , DNA/analysis , Enterocolitis/drug therapy , Enterocolitis/genetics , Feces/microbiology , Genomics , Hirschsprung Disease/genetics , Humans , Male , Pilot Projects , Polymerase Chain Reaction , Polymorphism, Single Nucleotide , Proto-Oncogene Proteins c-ret/genetics
5.
Intern Med J ; 39(5): 335-7, 2009 May.
Article in English | MEDLINE | ID: mdl-19545245

ABSTRACT

SPRY2 is an inducible inhibitor of signalling mediated by tyrosine kinases receptors, whose targeting causes intestinal hyperganglionosis in mice. In this light, we have undertaken a mutational analysis of the SPRY2 gene in patients affected with intestinal neuronal dysplasia (IND), without detecting nucleotide changes in any of the 26 DNA samples analysed, with the exception of two already known polymorphic variants. A role of the SPRY2 gene in IND pathogenesis can be thus excluded.


Subject(s)
Genetic Variation/genetics , Intestinal Diseases/genetics , Intracellular Signaling Peptides and Proteins/genetics , DNA Mutational Analysis , Gene Frequency/genetics , Humans , Intestinal Diseases/pathology , Intestinal Diseases/physiopathology , Membrane Proteins , Receptor Protein-Tyrosine Kinases/genetics , Signal Transduction/genetics
6.
Eur J Pediatr Surg ; 18(6): 407-9, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19061157

ABSTRACT

INTRODUCTION: The minimally invasive repair of pectus excavatum has become the preferred technique in most centres. One of the most important technical points for the final result is stabilisation of the bar, usually obtained by one or two metal stabilisers. Recently, long-term absorbable stabilisers have become available (LactoSorb, Biomet, Jacksonville, FL, USA). Made of poly-L-lactic and polyglycolic acid, they have been introduced with the aim of reducing local discomfort and making removal of the bar easier. Their efficacy for the stabilisation of the bar has not been proved yet. In this paper we compare the surgical outcome in two groups of patients, one treated with metallic and the other with absorbable stabilisers. MATERIAL AND METHODS: A total of 280 patients underwent pectus excavatum repair using a Nuss technique in two centres. In 194 patients (group 1), operated on since 2001, the metallic stabiliser was used. In 86 patients (group 2), operated on since February 2007, the LactoSorb stabiliser was preferred. We compared both groups in terms of surgical details, local symptoms or complications, and bar instability rate. RESULTS: The surgical technique for the stabilisation of the bar was identical in both groups, but in group 1 the stabiliser was fastened to the bar with a steel wire, while in group 2 polyglycolic sutures were used. No differences in local discomfort or postoperative pain were observed between the groups. The LactoSorb stabiliser was palpable for at least 6-9 months, and progressively disappeared at 9-12 months. In group 1 we observed 6 local complications. In particular, two patients presented with infection, one of them associated with a skin lesion and opening over the metallic stabiliser (revision of the wound was performed). Another patient developed a thoracic wall haematoma after suffering a trauma over the metallic stabiliser, 13 months after operation. Three patients developed a seroma. In group 2 we observed 3 subcutaneous swellings at the site of the LactoSorb stabiliser at 6, 8 and 9 months after the operation. We did not observe either skin lesions or infections. In the group with metallic stabiliser, 3 patients (1.5 %) had bar dislocation, while we did not observe bar instability in the group with LactoSorb stabiliser. CONCLUSIONS: LactoSorb stabiliser is safe and effective for stabilising the bar in pectus surgery. We suggest its routine use as it appears to be less traumatic and could make bar removal easier.


Subject(s)
Absorbable Implants , Biocompatible Materials , Funnel Chest/surgery , Lactic Acid , Polyglycolic Acid , Surgical Fixation Devices , Adolescent , Adult , Child , Humans , Metals , Minimally Invasive Surgical Procedures , Polylactic Acid-Polyglycolic Acid Copolymer , Retrospective Studies , Surgical Fixation Devices/adverse effects , Treatment Outcome
7.
Minerva Ginecol ; 60(4): 273-9, 2008 Aug.
Article in Italian | MEDLINE | ID: mdl-18560341

ABSTRACT

AIM: To investigate a possible relationship between preoperative platelet count and following clinicopathological variables of the endometrial carcinoma: age, stage, histological type, histological grading (G), myometrial invasion, lymphovascular space involvement, cervical involvement, lymph node metastasis. In particular the existence of a possible relationship between elevated preoperative platelet count (=or>300 000 microL) and negative prognostic factors. METHODS: The authors analyzed retrospectively 120 patients with endometrial carcinoma underwent to surgery as the initial treatment. All the patients were subjected to radical surgical procedure: peritoneal cytology, total abdominal hysterectomy, bilateral salpingo-oophorectomy, systematic pelvic lymphadenectomy and omentectomy. Blood platelet count was taken from the patients three days prior to the surgery. RESULTS: The patients with platelet count<300000/microL whom they had a G1, G2, G3 they were respectively the 23.1%, 44.2% and 32.7% versus the 0%, 12.5% and 87.5%, respectively for G1, G2, G3, of the patients with platelet count>300000/microL (P=0.024). Only considering the patients to the stage I of the Federazione Internazionale dei Ginecologi ed Ostetrici (FIGO). The patients with platelet count<300000/microL whom they had a G1, G2, G3 they were respectively the 27.3%, 43.2% and 29.5% versus the 0%, 0% and 100%, respectively for G1, G2, G3, of the patients with platelet count=or>300000/microL (P=0.008). There were no differences respect to age, stage, histological type, myometrial invasion, lymphovascular space involvement and cervical involvement. CONCLUSION: Elevated preoperative platelet count, in the patients with endometrial carcinoma, may reflect poor prognostic factor such as higher histological grade. This study allowed to observe: a significant correlation between elevated preoperative platelet count (=or>300000/microL) and tumoral grading (G3) of general population submitted to study; for the patients to the stage I FIGO a more significant correlation between elevated preoperative platelet count (=or>300000/microL) and tumoral grading: the 100% of the patients with platelet count=or>300 000/microL had a histological grading G3.


Subject(s)
Endometrial Neoplasms/pathology , Platelet Count , Uterine Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Algorithms , Endometrial Neoplasms/blood , Endometrial Neoplasms/surgery , Female , Humans , Hysterectomy , Italy , Lymph Node Excision , Middle Aged , Neoplasm Invasiveness , Neoplasm Staging , Predictive Value of Tests , Preoperative Care/methods , Prognosis , Retrospective Studies , Sensitivity and Specificity , Uterine Neoplasms/blood , Uterine Neoplasms/surgery
8.
Surg Endosc ; 21(10): 1772-5, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17356939

ABSTRACT

BACKGROUND: Few reports have elucidated the role of minimally invasive surgery (MIS) for pediatric malignancies. This study aimed to review the results of a multicenter study on the management of thoracic tumors in children using MIS. METHODS: A 5-year retrospective review of all MIS procedures for the treatment of pediatric malignancies performed in seven centers belonging to the Italian Society of Videosurgey in Infancy is reported. The data from 145 pediatric oncologic patients (80 girls and 65 boys) ages 30 days to 17 years (median, 7.2 years) were analyzed. Of the procedures performed, 87 were laparoscopies (60%), 55 were thoracoscopies (38%), and 3 were lumboscopies (2%). This study focused only on the results of the 55 thoracoscopic procedures performed for diagnostic purposes in 19 cases (34.6%) and for therapeutic purposes in 36 cases (65.4%). RESULTS: The duration of surgery was 15 to 180 min (median, 65 min). Metastasectomies were performed for various etiologies in 31 of the 55 cases. Of the 55 patients, 5 underwent resection of a mediastinal tumor, and 19 underwent a diagnostic thoracoscopy. During a mean follow-up period of 25.6 months, 2 (3.6%) of the 55 patients experienced perioperative complications. CONCLUSIONS: The role of MIS in tumor resection for children is currently limited, but may be used in individual cases when the preoperative workup shows it to be feasible. Its indication is strictly dependent on the thoracoscopic experience of the surgeon and the tumor site for preoperative imaging techniques. When the indication for thoracoscopy is correct, this approach has high therapeutic applicability (65.4% in our series). Our preliminary experience shows that careful patient selection and an appropriate level of technical skill make thoracoscopy a reasonable and safe option for the treatment of pediatric malignancies.


Subject(s)
Thoracic Neoplasms/surgery , Thoracoscopy , Adolescent , Child , Child, Preschool , Data Collection , Female , Humans , Infant , Male , Retrospective Studies
9.
Surg Endosc ; 21(4): 527-31, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17287922

ABSTRACT

BACKGROUND: Some technical aspects of laparoscopic spleen surgery still are debated, although efforts have been made to standardize them. The position of the patient, the approach to the spleen, vessel identification and division, and spleen extraction can vary from center to center. METHODS: This retrospective muticentric study led by the Società Italiana di Videochirurgia Infantile (SIVI) examined indications, surgical details, and complications of laparoscopic spleen surgery in the pediatric population during a 5-year period. RESULTS: The study period from January 1999 to December 2003 (5 years) involved nine centers and included 85 patients with a mean age of 10 years (range, 2-17 years). Hypersplenism or severe hemolysis in cases of hematologic disorders represented the most important indications. More than 90% of the patients underwent total laparoscopic splenectomy. Specific technical details from each center were collected. Intraoperative complications occurred in 19% of the patients (hemorrhage in 8% and technical problems in 14%), and 6% of the patients required conversion to the open approach. No deaths occurred, and no reoperations were required. Postoperative complications were experienced by 2% of the patients. CONCLUSION: Laparoscopic spleen surgery is safe, reliable, and effective in the pediatric population. On the basis of the results, some technical details for laparoscopic spleen surgery can be suggested. The patient is preferably kept supine or lateral, approaching the spleen anteriorly. Moreover, the ilar vessels should be identified selectively and individually, with initial artery division performed to achieve spleen shrinking. Any hemostatic device proved to be effective in experienced hands. Once freed, the spleen is preferably extracted via a suprapubic cosmetic transverse incision (faster, easier, and safer), although a bag can be used. Finally, the size of the spleen does not represent a contraindication for a trained and experienced surgeon. Nevertheless, this parameter must be considered when laparoscopic spleen surgery is planned.


Subject(s)
Intraoperative Complications/diagnosis , Laparoscopy/methods , Postoperative Complications/diagnosis , Splenectomy/methods , Splenic Diseases/diagnosis , Splenic Diseases/surgery , Adolescent , Age Distribution , Child , Child, Preschool , Data Collection , Female , Hematologic Diseases/complications , Hematologic Diseases/diagnosis , Humans , Incidence , Intraoperative Complications/epidemiology , Italy , Laparoscopy/adverse effects , Male , Pediatrics/methods , Postoperative Complications/epidemiology , Prognosis , Retrospective Studies , Risk Assessment , Severity of Illness Index , Sex Distribution , Splenectomy/adverse effects , Splenic Diseases/etiology , Survival Analysis
10.
Eur J Pediatr Surg ; 17(1): 34-40, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17407019

ABSTRACT

INTRODUCTION: Neural crest (NC) cells differentiate IN VITRO into neuroblasts, precursors of the enteric nervous system (ENS), when stimulated by specific agents. We developed a study aimed at establishing whether NC-derived neuroblasts can survive and colonise IN VIVO when injected into a recipient mouse gut. MATERIALS AND METHODS: The neuroblast precursors of the ENS were obtained from the vagal portion of the neural tubes of 296 CD-1 and GTROSA26 mouse embryos. The embryonic cells of GTROSA26 mice are identifiable through beta-galactosidase activity which allows recognition by blue staining. The host used in this study was the DOM/+ mouse, an animal model for Hirschsprung's disease (aganglionic megacolon). DOM/+ mouse pups (n = 43) received NC-derived cells inoculated into the seromuscular layer of the gut (33/43) or directly into the peritoneal abdominal cavity (10/43). RESULTS: All DOM/+ mice survived the procedure and were sacrificed after 7 or 14 days. Histochemical staining detected implanted cells in all mice. These showed specific myenteric colonisation into the aganglionic and ganglionic gut. CONCLUSION: The striking result of this study was the specific tropism of the injected NC-derived cells to target sites under the action of unknown chemotactic agents. This experimental procedure might represent a possible treatment option for specific forms of human ENS anomaly such as total intestinal aganglionosis.


Subject(s)
Cell Differentiation , Embryonic Stem Cells , Enteric Nervous System/cytology , Ganglia/cytology , Neural Crest/cytology , Stem Cell Transplantation , Animals , Cell Movement , Hirschsprung Disease/genetics , Immunohistochemistry , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Mice, Transgenic , Models, Animal
11.
Eur J Pediatr Surg ; 17(3): 176-9, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17638155

ABSTRACT

BACKGROUND: The necessity of carrying out pre- or intra-operative imaging of the biliary tree to rule out a possible anatomical abnormality or the presence of common bile duct (CBD) stones in patients undergoing laparoscopic cholecystectomy (LC) is debated. We prospectively assessed the risk of developing symptoms related to bile duct injury or CBD stones after LC in children not receiving peri-operative cholangiography. MATERIALS AND METHODS: All patients

Subject(s)
Cholangiography , Cholecystectomy, Laparoscopic , Elective Surgical Procedures/methods , Gallstones/diagnostic imaging , Gallstones/surgery , Preoperative Care/methods , Adolescent , Child , Child, Preschool , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Male , Prospective Studies , Reproducibility of Results , Time Factors , Treatment Outcome
12.
Surg Endosc ; 19(10): 1309-14, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16151683

ABSTRACT

BACKGROUND: This multicenter survey includes neonates and infants who underwent surgery for primary gastroesophageal reflux (GER) who presented with supraesophageal symptoms of unknown origin with a minimum of 12 months postoperative follow-up. METHODS: A total of 726 patients underwent GER surgery in 10 European Centers in the period 1998-2002. Respiratory symptoms were present in 204 patients (28%); 135 patients (17%) had surgery under 1 year of age, and 46 of them (6.3%) because of respiratory symptoms. Surgery was performed without any previous medical treatment in 10 cases (21%). The type of procedure included 37 complete 360 degrees wraps (80%) (Nissen, 12, and Rossetti, 25) and nine partial wraps (20%) (Thal five, Lortat Jacob one, Toupet one, others two). Gastrostomy was associated in 17 cases (37%) (6 PEG and 11 modified Stamm). No gastric emptying procedures were recorded. RESULTS: No major intraoperative complications were reported. Six patients developed complications (13%) and a redo operation was performed in three (6.5%). Respiratory outcome after antireflux surgery was good in 35 patients (76%) and fair with significantly improved respiratory symptoms in 11 (24%). CONCLUSIONS: This multicenter survey underlines that GER has to be suspected and aggressively treated in infants with difficult-to-treat supraesophageal symptoms, and also in high-risk cases, in order to prevent major complications.


Subject(s)
Gastroesophageal Reflux/surgery , Laparoscopy , Europe , Female , Gastroesophageal Reflux/complications , Humans , Infant , Male , Surveys and Questionnaires
13.
J Pediatr Surg ; 50(9): 1441-56, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25783403

ABSTRACT

BACKGROUND: Our study aims at disclosing epidemiology and most relevant clinical features of esophageal atresia (EA) pointing to a model of multicentre collaboration. METHODS: A detailed questionnaire was sent to all Italian Units of pediatric surgery in order to collect data of patients born with EA between January and December 2012. The results were crosschecked by matching date and place of birth of the patients with those of diagnosis-related group provided by the Italian Ministry of Health (MOH). RESULTS: A total of 146 questionnaires were returned plus a further 32 patients reported in the MOH database. Basing on a total of 178 patients with EA born in Italy in 2012, the incidence of EA was calculated in 3.33 per 10,000 live births. Antenatal diagnosis was suspected in 29.5% patients. 55.5% showed associated anomalies. The most common type of EA was Gross type C (89%). Postoperative complications occurred in 37% of type C EA and 100% of type A EA. A 9.5% mortality rate was reported. CONCLUSIONS: This is the first Italian cross-sectional nationwide survey on EA. We can now develop shared guidelines and provide more reliable prognostic expectations for our patients.


Subject(s)
Esophageal Atresia/epidemiology , Prenatal Diagnosis , Surveys and Questionnaires , Tracheoesophageal Fistula/epidemiology , Adult , Cross-Sectional Studies , Diagnosis-Related Groups , Esophageal Atresia/diagnosis , Female , Humans , Incidence , Infant, Newborn , Italy/epidemiology , Male , Pregnancy , Tracheoesophageal Fistula/diagnosis , Young Adult
14.
Am J Med Genet ; 47(6): 931-3, 1993 Nov 01.
Article in English | MEDLINE | ID: mdl-8279493

ABSTRACT

A new ectodermal dysplasia syndrome was reported by Bork et al. in 1987 (Hautarzt 38:342-347). The syndrome consisted of hypotrichosis with the typical SEM (scanning electron microscopy) changes of uncombable hair, retinal pigmentary dystrophy, juvenile cataract, oligodontia, brachydactyly with brachymetacarpia; it was inherited as an autosomal dominant trait. We describe a sporadic case and add further clinical findings to expand the spectrum of this rare syndrome.


Subject(s)
Bone and Bones/abnormalities , Cataract/genetics , Hair/abnormalities , Hypotrichosis/genetics , Retina/abnormalities , Tooth, Supernumerary/genetics , Child , Child, Preschool , Fingers/abnormalities , Hair/pathology , Hair/ultrastructure , Humans , Hypotrichosis/pathology , Male , Metacarpus/abnormalities , Microscopy, Electron, Scanning , Retina/pathology , Syndrome , Toes/abnormalities
15.
Ann N Y Acad Sci ; 734: 298-305, 1994 Sep 30.
Article in English | MEDLINE | ID: mdl-7978930

ABSTRACT

Epidermal growth factor receptor (EGF-R) has been implicated in the growth of endometrial cancer. In the present study, immunostaining of EGF-R was investigated in different endometrial cancer histotypes. For this purpose 34 surgical samples of primary endometrial carcinoma were studied using monoclonal anti-EGF-R antibody. The endometrial carcinomas were classified according to the International Society of Gynaecological Pathology (I.S.G.P.). EGF-R expression was observed in: 1 of 5 classical endometrioid adenocarcinomas (AE), in 8 of 9 endometrial adenocarcinomas with benign squamous metaplasia (AA), and in 3 of 14 adenosquamous adenocarcinomas (AS). In mucinous (M) and serous papillary adenocarcinoma (SP) EGF-R immunostaining was not observed. The EGF-R positivity was observed in endometrial cancer with squamous (SQ) differentiation, especially in those with benign SQ metaplasia. These results suggest that EGF-R immunostaining is related to the endometrial cancer histotype regardless of the tumor grade or extent of miometrial invasion.


Subject(s)
Endometrial Neoplasms/metabolism , Endometrial Neoplasms/pathology , ErbB Receptors/metabolism , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adenocarcinoma, Mucinous/metabolism , Adenocarcinoma, Mucinous/pathology , Carcinoma, Papillary/metabolism , Carcinoma, Papillary/pathology , Female , Humans
16.
Ann N Y Acad Sci ; 622: 376-82, 1991.
Article in English | MEDLINE | ID: mdl-1648321

ABSTRACT

Basement membranes (BM) are elements of the extracellular matrix that are essential for growth and differentiation of tissues. Several collagenolytic enzymes of tumor cells are involved in degradation of the extracellular matrix; growth and inhibitor factors [e.g. Epidermal Growth Factor (EGF), Transforming Growth Factors alpha and beta (TGF-alpha, beta)] seem to be involved in the extracellular matrix formation and degradation. To establish a possible association between the presence of collagenase (C), urokinase-type plasminogen activator (uPA) and the neoplastic growth of the endometrium, 44 endometrial specimens (14 proliferative, 11 secretive, 7 adenomatous hyperplasia, 12 adenocarcinoma) were studied using immunohistochemistry with antisera for C, uPA, EGF receptors and TGF-alpha. Immunostaining for collagenase revealed a positive reaction in moderately differentiated adeno-carcinoma without staining the normal and hyperplastic endometrium. A progressive increase in uPA immunostaining was observed in proliferative and neoplastic endometrium. TGF-alpha and its receptor (EGFr) were stained in proliferative and more clearly in hyperplastic and carcinomatous endometrium. In conclusion, BM play an important role in proliferation and differentiation of human endometrium; their degradation influences estrogen transportation from blood to the stroma. Endometrial BM degradation is associated with the presence of collagenolytic enzymes and growth factors.


Subject(s)
Endometrial Hyperplasia/chemically induced , Endometrium/drug effects , Peptide Hydrolases/physiology , Uterine Neoplasms/chemically induced , Adult , Basement Membrane/drug effects , Basement Membrane/physiology , Endometrial Hyperplasia/pathology , Endometrial Hyperplasia/physiopathology , Endometrium/pathology , Endometrium/physiology , ErbB Receptors/pharmacology , Female , Fibrinolytic Agents/pharmacology , Humans , Microbial Collagenase/pharmacology , Middle Aged , Plasminogen Activators/pharmacology , Transforming Growth Factor alpha/pharmacology , Urokinase-Type Plasminogen Activator/pharmacology , Uterine Neoplasms/pathology , Uterine Neoplasms/physiopathology
17.
Ann N Y Acad Sci ; 622: 463-8, 1991.
Article in English | MEDLINE | ID: mdl-2064202

ABSTRACT

Progesterone (P) and progestins play an important role in the control of endometrial growth. We have investigated P and progestin effects on endometrial estrogen extraction, on basement membrane (BM) synthesis and on the presence of the epidermal growth factor receptor (EGFr) in normal and pathologic endometrium. E2 uptake, evaluated in human isolated perfused uteri is significantly decreased by P. BMs investigated using immunohistochemistry, with antisera to collagen IV and laminin, were found around stromal cells only in the luteal phase or during P or progestin administration. Glandular BM, discontinuous in hyperplastic and carcinomatous endometria, were restored to integrity only in typical hyperplasia after therapy with progestin. Endometrial EGFr is modified by P: revelation of this antigen is increased in proliferative phase and decreased in secretory phase. Similarly this molecule was present in hyperplastic and carcinomatous endometria. Only in benign hyperplasia did we observe no staining for the same antigen after progestinic therapy. These data suggest that P or progestins may also have an indirect influence through mechanisms such as estrogen uptake and tissue factor activity with important differences between normal and pathologic endometrium.


Subject(s)
Cell Transformation, Neoplastic/drug effects , Progestins/pharmacology , Uterine Neoplasms/pathology , Adult , Cell Membrane/drug effects , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Cell Transformation, Neoplastic/pathology , Cell Transformation, Neoplastic/ultrastructure , Collagen/metabolism , Endometrial Hyperplasia/metabolism , Endometrial Hyperplasia/pathology , Endometrium/drug effects , Endometrium/metabolism , Endometrium/pathology , ErbB Receptors/metabolism , Female , Humans , Immunohistochemistry , Laminin/metabolism , Middle Aged , Neoplasm Invasiveness , Progesterone/pharmacology , Transforming Growth Factor alpha/metabolism , Uterine Neoplasms/ultrastructure
18.
Ann N Y Acad Sci ; 622: 256-65, 1991.
Article in English | MEDLINE | ID: mdl-1905894

ABSTRACT

The unpredictable response of endometriosis to steroids and its recurrence after therapy, led us to hypothesize a possible further control of this pathology by factors other than steroids. The presence of estrogen, progesterone and epidermal growth factor receptors (ER, PR, EGFr) was evaluated using immunohistochemistry before and after therapy with Danazol or a gonadotropin-releasing hormone analogue (GnRHa), Buserelin. EGFr, ER and PR were present in 100% of endometrial specimens, and in 71%, 29% and 49% of endometriotic implants, respectively. Danazol and GnRHa reduced immunohistochemical staining for EGFr antisera in the endometrial and endometriotic specimens. About 21% of endometriosis were EGFr positive and ER negative, suggesting a potential role of epidermal growth factor in growth and maintenance of endometrial ectopia.


Subject(s)
Endometriosis/physiopathology , ErbB Receptors/physiology , Receptors, Estrogen/physiology , Receptors, Progesterone/physiology , Adult , Buserelin/pharmacology , Danazol/pharmacology , Dinoprostone/blood , Endometriosis/metabolism , Endometriosis/pathology , Endometrium/metabolism , Endometrium/physiology , Endometrium/ultrastructure , ErbB Receptors/drug effects , ErbB Receptors/metabolism , Female , Follicle Stimulating Hormone/blood , Humans , Immune Sera/immunology , Immunohistochemistry , Luteinizing Hormone/blood , Progesterone/blood , Receptors, Estrogen/drug effects , Receptors, Estrogen/metabolism , Receptors, Progesterone/drug effects , Receptors, Progesterone/metabolism
19.
Fertil Steril ; 47(1): 122-9, 1987 Jan.
Article in English | MEDLINE | ID: mdl-3792566

ABSTRACT

Human uteri were perfused with Krebs-Ringer bicarbonate-glucose buffer with and without estrogens and progesterone for a period of up to 48 hours to preserve a viable organ, which was responsive to hormones. Flow rates of 12 to 35 ml/minute per artery were fully distributed into the organ, with pressure values ranging from 80 to 120 mm Hg. Arteriovenous gradients of oxygen and carbon dioxide tensions as well as the levels of lactate, lactic dehydrogenase, and creatine kinase released in the perfusate, indicators of tissue ischemia or cell necrosis, showed a good preservation of the organ for up to 48 hours. The light- and electron-microscopic examinations of endometrial and myometrial tissues taken before and during perfusion confirmed this result. The extracorporeal perfusion of uteri with buffer containing estrogens plus progesterone exhibited secretive modifications of the proliferative endometrium, thus suggesting the viability of the organ and its responsiveness to sex steroids.


Subject(s)
Endometrium/drug effects , Estrogens/pharmacology , Organ Preservation/methods , Progesterone/pharmacology , Uterus , Adult , Female , Humans , In Vitro Techniques , Perfusion , Time Factors
20.
Fertil Steril ; 55(4): 742-5, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1826278

ABSTRACT

Twenty-four hirsute women were treated with an inversal sequential scheme of cyproterone acetate, 50 mg/d by oral route from the 1st to the 15th day of the menstrual cycle, along with 100 micrograms/24 h of 17 beta-estradiol transdermally administered from days 1 to 21, for nine cycles at weekly intervals. The acne and seborrhea as well as hirsutism showed a significant improvement in all subjects studied. The plasma testosterone and dehydroepiandrosterone sulfate decrease from 1.5 +/- 1.3 ng/mL and 6.9 +/- 1.3 micrograms/mL to 0.5 +/- 0.03 ng/mL and 2.7 +/- 1.7 micrograms/mL, respectively. Similar values were observed in subjects with idiopathic hirsutism during the treatment. The metabolic parameters, as well as the plasma levels of sex hormone-binding globulin, appeared unaffected by the therapy. Furthermore, the luteinizing hormone and follicle-stimulating hormone secretion was strongly inhibited from the first cycle of treatment. In conclusion, considering the good clinical results and the avoidance of any hepatic effect, this association should be taken into account in the treatment of hirsutism, especially in case of oral estrogen intolerance.


Subject(s)
Cyproterone/analogs & derivatives , Estradiol/administration & dosage , Hirsutism/drug therapy , Administration, Cutaneous , Administration, Oral , Adult , Androgen Antagonists/therapeutic use , Cyproterone/administration & dosage , Cyproterone/therapeutic use , Cyproterone Acetate , Dehydroepiandrosterone/analogs & derivatives , Dehydroepiandrosterone/blood , Dehydroepiandrosterone Sulfate , Estradiol/therapeutic use , Female , Humans , Middle Aged , Sex Hormone-Binding Globulin/analysis , Testosterone/blood
SELECTION OF CITATIONS
SEARCH DETAIL